STRAP — Strategic Partners A/S Share News
0.000.00%
Last trade - 00:00- DKK31.66m
- DKK31.58m
- DKK0.31m
Brief: Orphazyme Announces Withdrawal Of European Marketing Authorisation Application For Arimoclomol
Brief: Orphazyme Has Filed For Voluntary Delisting Of ADS
Brief: Orphazyme: Notice Of In-Court Restructuring Proceedings
U.S. STOCKS ON THE MOVE-Docusign, Chevron Corp, Lazydays Holdings
U.S. STOCKS ON THE MOVE-DiDi, Rivian, Tilly's Inc
Brief: Commencement Of In-Court Restructuring Of Orphazyme A/S
Orphazyme falls on plan to restructure and cut jobs
Brief: Orphazyme Says Decided To File Petition For An In-Court Restructuring
Brief: Anders Vadsholt Takes Over As CEO Of Orphazyme
Brief: Orphazyme Announces Update On Regulatory Review Of Arimoclomol In The European Union
Brief: Orphazyme Announces Update On Regulatory Review Of Arimoclomol In The European Union
Brief: Orphazyme Updates On NDA Resubmission For Arimoclomol In The United States
Brief: Orphazyme To Present Additional Data On Arimoclomol’S Mechanism Of Action During 2022 Annual Worldsymposium
Brief: Orphazyme: Anders Vadsholt To Be Appointed CEO
Brief: Orphazyme Says Sees 2021 Net Revenue Range Narrowed To DKK 35 Mln to DKK 37 Mln
Brief: Orphazyme Announces Changes To The Board Of Directors
Brief: Orphazyme Establishes U.S. Offering Program With Cowen
Brief: Reg-Orphazyme Provides Regulatory Update Following Type A Meeting With FDA On Arimoclomol In Niemann-Pick Disease Type C
Brief: Orphazyme Files For Stock Shelf Of Up To $75 Million